APPARATUS, METHODS AND COMPUTER-READABLE MEDIUM FOR EFFICIENT ELECTRICAL GRID MEASUREMENTS

    公开(公告)号:US20210231716A1

    公开(公告)日:2021-07-29

    申请号:US16744805

    申请日:2020-01-16

    Abstract: Respective phasor values are recursively computed from respective ones of a series of signal samples for a node of a power system such that each phasor value is computed from a previously computed phasor value. Frequency values are recursively computed from the phasor values for respective ones of the signal samples. Recursive computing of frequency values may include computing respective phase angle values from respective ones of the phasor values, recursively computing coefficient values for a polynomial that fits the phase angle values, and recursively computing the frequency values from the coefficient values. The samples may be generated at a sampling rate and the phasor values and the frequency values may be produced at a rate that is the same as the sampling rate. Embodiments may provide methods, apparatus and computer readable media that implement such operations.

    PHARMACEUTICAL COMPOSITIONS FOR TREATING BREAST CANCERS AND METHODS OF USES THEREOF

    公开(公告)号:US20210228529A1

    公开(公告)日:2021-07-29

    申请号:US17151108

    申请日:2021-01-15

    Abstract: This invention relates to the treatment of breast cancer in a subject, and the subject can be either a male or female subject. Including methods of: treating metastatic breast cancer; refractory breast cancer; AR-positive breast cancer; AR-positive refractory breast cancer; AR-positive metastatic breast cancer; AR-positive and ER-positive breast cancer; triple negative breast cancer; advanced breast cancer; breast cancer that has failed selective estrogen receptor modulator (SERM) (tamoxifen, toremifene, raloxifene), gonadotropin-releasing hormone (GnRH) agonist (goserelin), aromatase inhibitor (AI) (letrozole, anastrozole, exemestane), cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor (palbociclib (Ibrance), ribociclib (Kisqali), lerociclib, abemaciclib (Vorzenio), trilaciclib, lerociclib), mTOR inhibitor (everolimus), trastuzumab (Herceptin, ado-trastuzumab emtansine), pertuzumab (Perjeta), alpelisib (Piqray) (an inhibitor of phosphatidylinositol-3-kinase subunit alpha (PI3Kα)), lapatinib, neratinib (Nerlynx), olaparib (Lynparza) (an inhibitor of the enzyme poly ADP ribose polymerase (PARP)), bevacizumab (Avastin), and/or fulvestrant treatments; metastasis in a subject suffering from breast cancer; HER2 -positive; treating a subject suffering from ER mutant expressing breast cancer and/or treating breast cancer in a subject, by first determining the 18F-16β-fluoro-5α-dihydrotestosterone (18F-DHT) tumor uptake and identifying said subject as having AR-positive breast cancer based on 18F-DHT tumor uptake, comprising administering to the subject a therapeutically effective amount of a selective androgen receptor modulator (SARM) compound and a cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor.

    Mixed halide scintillators radiation detection

    公开(公告)号:US11060024B2

    公开(公告)日:2021-07-13

    申请号:US16453569

    申请日:2019-06-26

    Abstract: Mixed halide scintillation materials of the general formula AB(1−y)MyX′wX″(3−w), where 0≤y≤1, 0.05≤w≤1, A may be an alkali metal, B may be an alkali earth metal, and X′ and X″ may be two different halogen atoms, and of the general formula A(1−y)BMyX′wX″(3−w), where 0≤y≤1, 0.05≤w≤1, A maybe an alkali metal, B may be an alkali earth metal, and X′ and X″ are two different halogen atoms. The scintillation materials of formula (1) include a divalent external activator, M, such as Eu2+ or Yb2+. The scintillation materials of formula (2) include a monovalent external activator, M, such as Tl+, Na+ and In+.

    SERIES SELF-RESONANT COIL STRUCTURE FOR CONDUCTING WIRELESS POWER TRANSFER

    公开(公告)号:US20210193381A1

    公开(公告)日:2021-06-24

    申请号:US16756963

    申请日:2019-03-07

    Abstract: Disclosed is a series self-resonant coil structure for wireless power transfer that includes a top coil element that is configured in a spiral and planar arrangement and a bottom coil element that is configured in a spiral and planar arrangement that is substantially similar to the arrangement corresponding to the top coil element, wherein the top coil element and the bottom coil element are positioned in a stacked arrangement in relation to each other. The coil structure further includes a dielectric layer element that is planarly positioned in between the top coil element and the bottom coil element, wherein the top coil element, the bottom coil element, and the dielectric layer element are aligned to produce series-resonance in the coil structure.

Patent Agency Ranking